Milestone Scientific Inc. MLSS
Industrial Specialties · IPO 2015 · data as of November 13, 2026
Milestone Scientific Inc. (MLSS) is a healthcare company listed in the US with a market value of about $28M. In the twelve months to September 30, 2026 it had revenue of $9M and net income of -$4M, a net margin of -38.3%.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is track record (1/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 11% a year, a 5-year average ROIC of -88%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 93% below the current price.
About Milestone Scientific
Milestone Scientific is listed in the US and classified in industrial specialties, IPO year 2015. Revenue went from $10M in 2014 to $9M in 2025, a decline of about 1.3% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 16% over three years (dilution for shareholders). It spends 5% of revenue on research and development.
Score: 0.4 / 5
Checks passed
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $9M | $9M | $10M | $9M | $10M | $5M | $8M | $10M | $11M | $10M |
| Net income | -$4M | -$6M | -$5M | -$7M | -$9M | -$7M | -$7M | -$8M | -$7M | -$5M | -$6M |
| Free cash flow | -$1M | -$3M | -$3M | — | -$6M | -$4M | -$7M | -$2M | -$2M | -$1M | -$5M |
| EPS (diluted) | $-0.04 | $-0.07 | $-0.06 | $-0.10 | $-0.12 | $-0.10 | $-0.12 | $-0.16 | $-0.21 | $-0.16 | $-0.22 |
| Net margin | -38.3% | -63.8% | -54.6% | -70.5% | -98.9% | -66.2% | -134.9% | -89.8% | -77.2% | -46.0% | -56.7% |
| ROIC | — | -151.1% | -87.3% | -84.6% | -82.5% | -34.4% | -34.4% | -184.5% | -370.4% | -57.1% | -76.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $1.25, 307% above the current price; targets range from $1.00 to $1.50; the consensus rating is “none”; expected EPS is $-0.04 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Milestone Scientific stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 93% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Milestone Scientific pay a dividend?
Not currently.
Is Milestone Scientific a good stock to buy?
We do not give buy or sell advice. Milestone Scientific scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.